{
    "medicine_id": "6cbac70a7fbe8d226d10a39476801244ff4d8958",
    "platform_id": "DB04339",
    "metadata": {
        "name": "Rejuvesol 7 5 g Syrup",
        "composition": "7 5 g Carbocisteine",
        "clinical_particulars": {
            "therapeutic_indications": "Used to help relieve the symptoms of chronic obstructive pulmonary disorder COPD and bronchiectasis",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00222",
                        "description": "The risk or severity of adverse effects can be increased when Glimepiride is combined with Carbocisteine"
                    },
                    {
                        "drugbank-id": "DB00414",
                        "description": "The risk or severity of adverse effects can be increased when Acetohexamide is combined with Carbocisteine"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "The risk or severity of adverse effects can be increased when Chlorpropamide is combined with Carbocisteine"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "The risk or severity of adverse effects can be increased when Tolazamide is combined with Carbocisteine"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "The risk or severity of adverse effects can be increased when Glyburide is combined with Carbocisteine"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "The risk or severity of adverse effects can be increased when Glipizide is combined with Carbocisteine"
                    },
                    {
                        "drugbank-id": "DB01120",
                        "description": "The risk or severity of adverse effects can be increased when Gliclazide is combined with Carbocisteine"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "The risk or severity of adverse effects can be increased when Tolbutamide is combined with Carbocisteine"
                    },
                    {
                        "drugbank-id": "DB01251",
                        "description": "The risk or severity of adverse effects can be increased when Gliquidone is combined with Carbocisteine"
                    },
                    {
                        "drugbank-id": "DB01289",
                        "description": "The risk or severity of adverse effects can be increased when Glisoxepide is combined with Carbocisteine"
                    },
                    {
                        "drugbank-id": "DB08962",
                        "description": "The risk or severity of adverse effects can be increased when Glibornuride is combined with Carbocisteine"
                    },
                    {
                        "drugbank-id": "DB13406",
                        "description": "The risk or severity of adverse effects can be increased when Carbutamide is combined with Carbocisteine"
                    },
                    {
                        "drugbank-id": "DB13675",
                        "description": "The risk or severity of adverse effects can be increased when Metahexamide is combined with Carbocisteine"
                    },
                    {
                        "drugbank-id": "DB00400",
                        "description": "The risk or severity of adverse effects can be increased when Griseofulvin is combined with Carbocisteine"
                    },
                    {
                        "drugbank-id": "DB00446",
                        "description": "The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Carbocisteine"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of adverse effects can be increased when Disulfiram is combined with Carbocisteine"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of adverse effects can be increased when Metronidazole is combined with Carbocisteine"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The risk or severity of adverse effects can be increased when Ketoconazole is combined with Carbocisteine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}